FDA
-
-
-
-
-
-
-
Teva Pharma (TEVA) Gets FDA Ok For aNDA For Ferric Citrate Anhydrous
-
-
-
-
-
-
-
Pancreatic Cancer Survival Gains Accelerate as Novel Therapies Advance
-
-
-
-
-
-
-
FDA approves UZEDY for bipolar I disorder maintenance treatment
-
-
-
-
-
-
-
Alvotech (ALVO) and Teva (TEVA) Announce FDA Approval of Interchangeability for SELARSDI with Stelara
-
-
-
-
-
-
-
Catalyst Pharmaceuticals (CPRX) Announces Settlement of FIRDAPSE Patent Litigation with Teva Pharmaceuticals
-
-
-
-
-
-
-
Immuneering Granted Orphan Drug Designation for IMM-1-104 by FDA in the Treatment of Pancreatic Cancer
-
-
-
-
-
-
-
Teva Pharma (TEVA) Provides Update on Pivotal Clinical Phase 3 of Investigational Olanzapine LAI and UZEDY Commercial Progress
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

